Quantum Biopharma has announced the purchase of an additional $1 million worth of Bitcoin and other cryptocurrencies, increasing its total crypto holdings to approximately $4.5 million. This move aligns with the company's strategy to stake a portion of its assets to generate revenue and aims to provide a return on investment for shareholders. Following the announcement, shares of Quantum’s stock rose by around 25%. As corporate treasuries become increasingly popular in the healthcare sector, Quantum joins other companies like Atai Life Sciences and Basel Medical Group in accumulating Bitcoin. These companies view Bitcoin as a hedge against inflation and as a means to maintain financial stability during lengthy drug approval processes. Collectively, corporate treasuries hold over $83 billion in Bitcoin, making them significant institutional holders in the crypto market. The trend signifies a broader adoption of Bitcoin as a strategic financial tool for companies in volatile economic climates.

Source 🔗